Evidence map›Paper›PMID 41959170›Full record

ArticlebioRxiv : the preprint server for biology2026

BenchDrop-seq: a microfluidics-free platform for benchtop single-cell long-read RNA sequencing.

Jamie Bregman, Calen Nichols, Rajeev Ramisetti, Avi Srivastava

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jamie BregmanGenome Regulation and Cell Signalling Program, The Wistar Institute, PA.
Calen NicholsGenome Regulation and Cell Signalling Program, The Wistar Institute, PA.
Rajeev RamisettiGenome Regulation and Cell Signalling Program, The Wistar Institute, PA.
Avi SrivastavaGenome Regulation and Cell Signalling Program, The Wistar Institute, PA.ORCID 0000-0001-9798-2079

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Aaron Robert Goldman · 1985 to 2026
$75.9M
Integrated analyses of the epigenome to understand the molecular basis of hematopoietic malignanciesR00CA267677 · NCI · WISTAR INSTITUTE · PI SRIVASTAVA, AVI · 2023 to 2025
$731k
NCI NIH HHS P30 CA010815NCI NIH HHS R00 CA267677
6 · The paper itself

Abstract

Single-cell long-read RNA sequencing enables direct measurement of full-length transcripts but has remained difficult to deploy at scale due to reliance on microfluidic barcoding, specialized instrumentation, and high per-cell cost. Here we present BenchDrop-seq, a benchtop platform for single-cell long-read transcriptomics that leverages particle-templated partitioning for single-cell molecular barcoding and couples this workflow to Oxford Nanopore sequencing for full-length transcript capture. By integrating established bead-based partitioning chemistry with long-read sequencing and a dedicated open-source analysis pipeline for barcode recovery, alignment, and transcript quantification, BenchDrop-seq enables isoform-resolved measurements from thousands of individual cells using standard laboratory equipment. We validate the platform in both a homogeneous cell line and a heterogeneous primary tissue, demonstrating high barcode recovery, accurate gene-level quantification, and reproducible detection of cell-type-specific transcript usage that is not readily accessible to short-read assays. Together, BenchDrop-seq establishes a practical and accessible framework for single-cell long-read RNA sequencing, lowering experimental barriers while enabling transcript-level analyses in routine single-cell experiments.

Indexed as

Long-read sequencingOxford Nanopore TechnologyRNA-seq quantificationSingle-cell RNA-seqTranscript Isoforms

Identifiers

PMID41959170
PMCPMC13061021

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.